Researchers reported key differences in atopic dermatitis presentation across racial groups and steps clinicians can take to ...

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

A new study conducted by researchers at National Jewish Health has found that early changes in the cheek skin barrier may ...

FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial shows significant symptom reduction ...

Ashley Lora joined an eczema clinical trial for DUPIXENT and paved the way for other Black women to try clinical trials.

Apogee conducted third-party quantitative market research in April 2025 and asked US patients and physicians the likelihood that they would switch to APG777 from their current or previous biologic ...

Atopic dermatitis (AD) presents as a long-term, recurring inflammatory disorder of the skin, and its characteristic itching significantly affects patients' daily living standards. The research was ...

Check out the links below to see the weekly stat leaders from Wednesday, April 23, to Tuesday, April 29, in six statistical categories: points, goals, assists, saves, ground balls and faceoffs won.

Dupixent is already approved to treat atopic dermatitis, as well as other indications involving type 2 inflammation, including severe asthma, chronic rhinosinusitis with nasal polyposis ...

“Nah, not at all, man,” celebrity barber Vince Garcia exclusively told Us Weekly. “That’s a full head of hair right there.” Garcia, who is based in Los Angeles, last had Kelce in his ...

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent ... several type 2 inflammatory diseases like atopic dermatitis and asthma and has demonstrated ...

Please enjoy the latest edition of Short Circuit, a weekly feature written by a bunch of people at the Institute for Justice. New on the Bound By Oath podcast: In 1974, Congress added the law ...